US Map / California
State CA

Clinical Trials in California

California is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in California and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 850 actively recruiting studies with California sites out of 850 registered in total. The busiest research areas in California are Breast Cancer, Ovarian Cancer, Colorectal Cancer. Leading sponsors running trials in the state include Stanford University, University of California, San Francisco, City of Hope Medical Center. By stage, California trials break down as Phase 1 (168), Phase 2 (228), Phase 3 (167), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
850
Recruiting Now
850
← Back to US Map
Top Conditions in California
Breast Cancer (22)Ovarian Cancer (15)Colorectal Cancer (13)Acute Myeloid Leukemia (12)Endometrial Cancer (11)Obesity (9)Solid Tumor (9)Prostate Cancer (9)Autism Spectrum Disorder (9)Lung Cancer (8)Multiple Myeloma (8)Schizophrenia (8)

Frequently Asked Questions — Clinical Trials in California

How many clinical trials are currently recruiting in California?
ClinicalMetric currently tracks 850 actively recruiting clinical trials with at least one location in California. The total number of registered studies—including active but not currently enrolling trials—is 850. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in California?
California hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout California serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in California?
To join a clinical trial in California, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in California maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in California

NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Enrollment
200 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
NCT07027306 N/A
Recruiting
The Osteoporotic Fracture Classification-based Scoring System for Treatment Deci...
Condition
Osteoporotic Fractures
Enrollment
648 pts
Location
United States, Argentina, Brazil
Sponsor
AO Foundation, AO Spine
View Trial →
NCT06860516 N/A
Recruiting
HLA Demographics Study in Adults With Type 1 Diabetes
Condition
Diabetes Mellitus, Type I
Enrollment
200 pts
Location
United States
Sponsor
GentiBio, Inc
View Trial →
NCT07451106 N/A
Recruiting
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physica...
Condition
Postpartum Bladder Dysfunction
Enrollment
25 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
View Trial →
NCT06721962 Phase 1, Phase 2
Recruiting
Treatment of Moderate to Severe Refractory Crohn's Disease
Condition
Crohns Disease
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
View Trial →
NCT04216732 N/A
Recruiting
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Managemen...
Condition
Advanced Thyroid Gland Medullary Carcinoma
Enrollment
2,030 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07244263 Phase 2
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa
Enrollment
90 pts
Location
United States, Australia, Canada
Sponsor
Takeda
View Trial →
NCT07503210 Phase 3
Recruiting
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Help...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
View Trial →
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT07094204 Phase 1
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Condition
Solid Tumor
Enrollment
364 pts
Location
United States, France, Japan
Sponsor
Astellas Pharma Inc
View Trial →
NCT07398417 Phase 3
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal ...
Condition
Fibromyalgia
Enrollment
620 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06565637 Phase 1
Recruiting
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minor...
Condition
Eating Disorders
Enrollment
30 pts
Location
United States
Sponsor
Auburn University
View Trial →
NCT00932139 N/A
Recruiting
Effect of Electro-Acupuncture on Blood Pressure
Condition
Hypertension
Enrollment
160 pts
Location
United States
Sponsor
University of California, Irvi
View Trial →
NCT03127267 Phase 3
Recruiting
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Condition
Amyotrophic Lateral Sclerosis
Enrollment
495 pts
Location
United States, Belgium, Denmark
Sponsor
AB Science
View Trial →
NCT04354545 N/A
Recruiting
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medic...
Condition
Glaucoma
Enrollment
75 pts
Location
United States
Sponsor
University of California, Los
View Trial →
NCT06634875 Phase 2
Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorect...
Condition
Colorectal Cancer Metastatic
Enrollment
20 pts
Location
United States
Sponsor
Buzzard Pharmaceuticals
View Trial →
NCT05775471 Phase 2
Recruiting
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radic...
Condition
Renal Pelvis and Ureter Urothelial Carcinoma
Enrollment
21 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
View Trial →
NCT06288009 N/A
Recruiting
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
Condition
Scarring
Enrollment
50 pts
Location
United States
Sponsor
University of California, Davi
View Trial →
NCT07029581 Phase 2
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Condition
Lewy Body Dementia Psychosis
Enrollment
180 pts
Location
United States, Bulgaria, Czechia
Sponsor
ACADIA Pharmaceuticals Inc.
View Trial →
NCT07169448 N/A
Recruiting
Food is Medicine Prospective Study
Condition
Wounds and Injuries
Enrollment
75 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
View Trial →
NCT07038343 Phase 1, Phase 2
Recruiting
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in P...
Condition
Solid Tumor Cancer
Enrollment
480 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
View Trial →
NCT06528301 Phase 1
Recruiting
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD...
Condition
Lymphoma, B-Cell
Enrollment
106 pts
Location
United States, Australia
Sponsor
Umoja Biopharma
View Trial →
NCT07227402 Phase 3
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney...
Condition
Renal Cell Carcinoma
Enrollment
904 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04830137 Phase 1
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
248 pts
Location
United States
Sponsor
Nurix Therapeutics, Inc.
View Trial →
Page 1 of 34 — 850 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology